Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
Holding CORT?
Track your performance easily

Corcept Therapeutics (CORT) Financial Statements

722 Followers

Corcept Therapeutics Financial Overview

Corcept Therapeutics's market cap is currently ―. The company's EPS TTM is $1.127; its P/E ratio is 40.30; Corcept Therapeutics is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $0.28. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 163.80M$ 146.81M$ 135.41M$ 123.60M$ 117.72M
Gross Profit$ 161.27M$ 144.27M$ 133.53M$ 121.96M$ 116.14M
EBIT$ 41.59M$ 34.99M$ 31.67M$ 36.38M$ 32.93M
EBITDA$ 41.79M$ 35.17M$ 32.30M$ 36.55M$ 33.75M
Net Income Common Stockholders$ 35.12M$ 27.51M$ 31.14M$ 31.17M$ 27.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 473.16M$ 410.76M$ 368.22M$ 355.23M$ 363.26M
Total Assets$ 714.55M$ 655.93M$ 621.52M$ 594.02M$ 524.63M
Total Debt$ 5.67M$ 76.00K$ 151.00K$ 225.00K$ 297.00K
Net Debt$ -467.49M$ -410.69M$ -368.07M$ -355.00M$ -362.96M
Total Liabilities$ 118.31M$ 108.07M$ 114.81M$ 132.34M$ 103.01M
Stockholders Equity$ 596.24M$ 547.86M$ 506.70M$ 461.68M$ 421.61M
Cash Flow-
Free Cash Flow$ 40.77M$ 23.76M$ 5.89M$ 52.87M$ 42.18M
Operating Cash Flow$ 41.18M$ 23.76M$ 5.89M$ 52.91M$ 42.29M
Investing Cash Flow$ -60.19M$ -9.01M$ 17.10M$ -109.57M$ -24.10M
Financing Cash Flow$ -2.15M$ -543.00K$ 766.00K$ -3.92M$ -145.75M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

Corcept Therapeutics Debt to Assets

Corcept Therapeutics Cash Flow

Corcept Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis